GSK surpasses profit expectations on pain medication stockpiling

(Reuters) - GlaxoSmithKline beat quarterly profit expectations on rising sales of its blockbuster shingles vaccine and strong demand for pain and respiratory medicines during the coronavirus pandemic.The maker of Advil and Panadol painkillers on Wednesday joined AstraZeneca and other large pharmaceuticals companies in sticking to or even raising full-year forecasts as lockdowns to combat the spread of the virus lead to stockpiling of medicines and other essentials.The British company said..